Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Mirvetuximab soravtansine: current and future applications
Beihua Kong,
Wenxin Zheng
Research output
:
Contribution to journal
›
Editorial
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Mirvetuximab soravtansine: current and future applications'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Folate Receptor 1
100%
Mirvetuximab Soravtansine
100%
Krukenberg Tumor
50%
Carcinoma in Situ
50%
Serous Carcinoma
50%
Neoplasm
25%
Health Care Cost
25%
Quality of Life
25%
Breast Cancer
25%
Personalized Medicine
25%
Cancer
25%
Clinical Trial
25%
Invasive Carcinoma
25%
Recurrence Risk
25%
High Risk Population
25%
Precursor
25%
Progression Free Survival
25%
Salpingooophorectomy
25%
Antibody-Drug Conjugate
25%
Familial Cancer
25%
Uterine Cancer
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Folate Receptor 1
100%
Mirvetuximab Soravtansine
100%
Carcinoma
50%
Ovary Carcinoma
50%
Carcinoma in Situ
50%
Clinical Trial
25%
Breast Cancer
25%
Neoplasm
25%
Invasive Carcinoma
25%
Recurrence Risk
25%
Progression Free Survival
25%
Endometrium Cancer
25%
Antibody Drug Conjugate
25%
Hereditary Tumor Syndrome
25%
Diseases
25%
Keyphrases
Therapeutic Versatility
25%